Vantis Gains Financing Support for CrossShock IVL and CrossFast Systems

May 21, 2024—Vantis Vascular, Inc. announced the successful closing of a $5 million financing round to support the commercial launch of the CrossFast integrated microcatheter guide extension system and accelerate the development of the CrossShock intravascular lithotripsy (IVL) system.

The CrossFast device features the company’s two-in-one DuoPro interlocking technology intended to provide enhanced control and maneuverability to traverse calcific and tortuous anatomies. The CrossShock IVL system utilizes a low-profile, microelectrode design.

The $5 million SAFE—Simple Agreement for Future Equity—financing is convertible upon Vantis’ future Series C preferred round, advised the company. It comes after a total raise of $24 million from individuals and National Institutes of Health grants.